172 related articles for article (PubMed ID: 27903934)
1. Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study.
Devorak J; Mokry LE; Morris JA; Forgetta V; Davey Smith G; Sawcer S; Richards JB
Mult Scler; 2017 Oct; 23(11):1461-1468. PubMed ID: 27903934
[TBL] [Abstract][Full Text] [Related]
2. The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis.
Harroud A; Manousaki D; Butler-Laporte G; Mitchell RE; Davey Smith G; Richards JB; Baranzini SE
Mult Scler; 2021 Nov; 27(13):1994-2000. PubMed ID: 33605807
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Mokry LE; Ross S; Ahmad OS; Forgetta V; Smith GD; Goltzman D; Leong A; Greenwood CM; Thanassoulis G; Richards JB
PLoS Med; 2015 Aug; 12(8):e1001866. PubMed ID: 26305103
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and coronary artery disease risk: A bi-directional Mendelian randomization study.
Au Yeung SL; Schooling CM
Int J Cardiol; 2018 Oct; 268():222-226. PubMed ID: 30041791
[TBL] [Abstract][Full Text] [Related]
5. Obesity and Multiple Sclerosis: A Mendelian Randomization Study.
Mokry LE; Ross S; Timpson NJ; Sawcer S; Davey Smith G; Richards JB
PLoS Med; 2016 Jun; 13(6):e1002053. PubMed ID: 27351487
[TBL] [Abstract][Full Text] [Related]
6. Plasma circulating vitamin C levels and risk of multiple sclerosis: a two-sample Mendelian randomization analysis.
Peng H; Wu X; Wen Y; Lin J
Mult Scler Relat Disord; 2021 Nov; 56():103267. PubMed ID: 34610567
[TBL] [Abstract][Full Text] [Related]
7. Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study.
Lu H; Wu PF; Zhang W; Xia K
Mult Scler Relat Disord; 2020 Sep; 44():102300. PubMed ID: 32590313
[TBL] [Abstract][Full Text] [Related]
8. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.
Wang R
J Transl Med; 2022 Jan; 20(1):3. PubMed ID: 34980161
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis.
Ge F; Huo Z; Li C; Wang R; Wang R; Liu Y; Chen J; Lu Y; Wen Y; Jiang Y; Peng H; Wu X; Liang H; He J; Liang W
Mult Scler Relat Disord; 2021 Jun; 51():102927. PubMed ID: 33812221
[TBL] [Abstract][Full Text] [Related]
10. Relationships between accelerometer-measured and multiple sclerosis: a 2-sample Mendelian randomization study.
Lu H; Wu PF; Li RZ; Zhang W; Huang GX
Neurol Sci; 2021 Aug; 42(8):3337-3341. PubMed ID: 33411191
[TBL] [Abstract][Full Text] [Related]
11. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Lu H; Wu PF; Zhang W; Liao X
Front Immunol; 2021; 12():647588. PubMed ID: 33936066
[TBL] [Abstract][Full Text] [Related]
12. Genetically Determined Serum Uric Acid and Alzheimer's Disease Risk.
Yuan H; Yang W
J Alzheimers Dis; 2018; 65(4):1259-1265. PubMed ID: 30149453
[TBL] [Abstract][Full Text] [Related]
13. Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study.
Harroud A; Morris JA; Forgetta V; Mitchell R; Smith GD; Sawcer SJ; Richards JB
Neurology; 2019 Apr; 92(16):e1803-e1810. PubMed ID: 30894442
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and the risk of gastrointestinal cancers in East Asians: Mendelian randomization analysis.
Jiang H; Hu D; Wang J; Zhang B; He C; Ning J
Cancer Med; 2022 Jun; 11(12):2397-2404. PubMed ID: 35384390
[TBL] [Abstract][Full Text] [Related]
15. Age-specific effects of childhood body mass index on multiple sclerosis risk.
Hone L; Jacobs BM; Marshall C; Giovannoni G; Noyce A; Dobson R
J Neurol; 2022 Sep; 269(9):5052-5060. PubMed ID: 35532785
[TBL] [Abstract][Full Text] [Related]
16. Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS.
Harroud A; Richards JB; Baranzini SE
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33214142
[TBL] [Abstract][Full Text] [Related]
17. Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.
Vandebergh M; Becelaere S; ; Dubois B; Goris A
Front Immunol; 2022; 13():834644. PubMed ID: 35386698
[TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study.
Dan YL; Wang P; Cheng Z; Wu Q; Wang XR; Wang DG; Pan HF
Rheumatology (Oxford); 2021 Feb; 60(2):940-946. PubMed ID: 32944772
[TBL] [Abstract][Full Text] [Related]
19. Childhood obesity and multiple sclerosis: A Mendelian randomization study.
Harroud A; Mitchell RE; Richardson TG; Morris JA; Forgetta V; Davey Smith G; Baranzini SE; Richards JB
Mult Scler; 2021 Dec; 27(14):2150-2158. PubMed ID: 33749377
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin affects estimated glomerular filtration rate: A two-sample bidirectional Mendelian randomization study.
Bai Y; Chen Z; Wen Z; Long X; Mo Z; Xu J
Nephrology (Carlton); 2021 Mar; 26(3):227-233. PubMed ID: 33484075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
